Glycemic variability closely associated with increase in risk of all-cause mortality Jacinthlyn Sylvia26 Oct 2022 8:15 PM ISTChina: In a new study conducted by Junxiang Chen and the team, it was found that the number of unfavorable outcomes related to diabetes that long-term...
High blood sugar in diabetes linked to development of trigger finger Dr. Kamal Kant Kohli26 Oct 2022 8:00 PM ISTTrigger finger or locked finger are more common among people with diabetes than in the general population. Researchers have found in a new study that...
What ADA consensus on hyperglycemia management has to say about DPP-4 inhibitors Medha Baranwal26 Oct 2022 9:30 AM ISTUSA: Early combination therapy with a DPP-4 inhibitor and metformin increases glycemic durability compared to a stepwise approach to therapy,...
SGLT2 inhibitors not linked to increased bladder cancer risk: Study Jacinthlyn Sylvia19 Oct 2022 8:15 PM ISTA recent study by Devin Abrahami published in the journal of Diabetes Care found that sodium-glucose cotransporter 2 (SGLT2) inhibitors are not...
Dual or single SGLT inhibition: which is more beneficial for type 2 diabetes? Study sheds light Medha Baranwal19 Oct 2022 9:30 AM ISTIn type 2 diabetes patients, the study did not indicate different clinical impacts of dual and single SGLT inhibition.Germany: Inhibition of...
Diabetes management in patients with CKD: Key takeaways from ADA and KDIGO guidance Dr Kartikeya Kohli8 Oct 2022 8:00 PM ISTUSA: The American Diabetes Association (ADA) and the Kidney Disease: Improving Global Outcomes (KDIGO) organization have released joint guidance on...
To prevent hypoglycemia, Discontinue sulfonylureas once insulin is initiated: ADA and EASD's Consensus update Medha Baranwal7 Oct 2022 12:00 PM ISTUSA: Agents such as sulfonylureas that cause hypoglycemia in themselves should be discontinued once insulin is initiated, a recent consensus report by...
Thiazolidinediones with high glucose-lowering efficacy reduce secondary CV endpoints; ADA and EASD's consensus Medha Baranwal4 Oct 2022 8:00 PM ISTUSA: Thiazolidinediones are oral medications having high glucose-lowering efficacy and durability of glycemic effect, according to a recent consensus...
SGLT2 inhibitors reduce HF, MACE and improve kidney outcomes in CKD: ADA/ EASD consensus report Medha Baranwal30 Sept 2022 12:00 PM ISTSGLT2 inhibitors should be used in patients with heart failure (HF) because they improve kidney and HF outcomes, according to a consensus report...
Hyperglycemia management in type 2 diabetes: Consensus update by ADA/EASD Medha Baranwal27 Sept 2022 11:30 AM ISTUSA: The American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) have released a new consensus update on the...
For remission of type 2 diabetes, bariatric surgery more effective than lifestyle Dr. Kamal Kant Kohli3 Sept 2022 9:00 AM ISTResearchers at Pennington Biomedical Research Center have found in a new study that Bariatric surgery is more effective than medications and lifestyle...
Factory-calibrated CGM accurate for diabetics on hemodialysis: Study Medha Baranwal22 July 2022 8:30 PM ISTA factory-calibrated continuous glucose monitor (CGM) appears to be reasonably accurate for individuals on hemodialysis, according to a new...
